Edwards Lifesciences EW
-
Edwards Lifesciences' CEO Hosts Annual Meeting of Stockholders Conference (Transcript)
Edwards Lifesciences Corp ( EW ) Annual Meeting of Stockholders ..... Annual Meeting of Stockholders for Edwards Lifesciences . I am Mike Mussallem, I’m the ..... appreciate your continued support of Edwards Lifesciences . As you may have seen, 2011 was …
-
Edwards Lifesciences ([[EW]] +0.9%) shrugs off this mornings weakness after the Centers for Medicare & Medical Services announced it will cover Transcatheter Aortic Valve Replacement procedures for ...
Edwards Lifesciences ( EW +0.9% ) shrugs off this mornings weakness after the Centers for Medicare & Medical Services announced it will cover Transcatheter …
-
US Medicare to cover Edwards Sapien heart valve
WASHINGTON, May 1 (Reuters) - The U.S. Medicare and Medicaid federal health insurance programs will cover the Sapien heart valve from Edwards Lifesciences Corp, U.S. regulators said on Tuesday.
-
New J&J (JNJ) CEO Alex Gorsky is looking to strengthen the company's medical-device unit via takeovers, he tells Bloomberg in an interview. "We remain committed to cardiovascular," Gorsky says, ...
… committed to cardiovascular," Gorsky says, despite sales shrinking 44% since 2006. On the analyst wish list are Edwards Lifesciences ( EW ) and St. Jude Medical ( STJ ). 1 comment!
-
Sapien Drives Revenue and Earnings Growth for Edward Lifesciences in 1Q
Edwards Lifesciences EW posted first-quarter results that were largely consistent with our expectations for revenue growth and profits. We are leaving …
-
Edwards Lifesciences Corporation's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Edwards Lifesciences Corporation ( EW ) Q1 2012 Earnings Call April 24, 2012 5:00 ..... Stanley Smith Barney Presentation Greetings, and welcome to the Edwards Lifesciences Corporation’s first quarter 2012 earnings conference call …
-
UPDATE 1-Edwards Q1 profit beats, but 2012 outlook cut
April 24 (Reuters) - Edwards Lifesciences Corp posted a better-than-expected quarterly profit on solid sales of a new heart valve, but cut its full-year outlook, citing a delay in U.S. approval of the product for an expanded group of patients.
-
Edwards Lifesciences (EW): Q1 EPS of $0.53 beats by $0.05. Revenue of $459M (+13.56% Y/Y) beats by $10M. Shares +3.7% AH. (PR)
Edwards Lifesciences ( EW ): Q1 EPS of $0.53 beats by $0.05 . Revenue of $459M (+13.56% Y/Y) beats by $10M . Shares +3.7% AH. ( PR ) Post your comment!
-
Edwards quarterly profit beats expectations
April 24 (Reuters) - Edwards Lifesciences Corp posted better-than-expected quarterly earnings on sales of a new heart valve, but the medical device maker said it now expects slower full-year sales...
-
Edwards Lifesciences : Earnings Preview
By Zacks Investment Research : Edwards Lifesciences Corporation ( EW ) is scheduled to release its first quarter fiscal 2012 results on Tuesday, April 24, 2012 after the market …